Story highlights
Ecuador envoy to India Hector Cueva Jacome is the first foreign envoy to be part of phase 3 covid vaccine trials in India
Ecuador s ambassador to India Hector Cueva Jacome has expressed his confidence in Indian COVID vaccines, highlighting that are part of the solution . He himself was part of phase-3 trials of Covaxin, the coronavirus vaccine developed by Bharat Biotech. Jacome is the first foreign envoy to be part of phase 3 covid vaccine trials in India. Covaxin recently got approval from India s drug regulator.
Ambassador Jacome hasn t exhibited any secondary effects of the vaccine so far and exclusively told WION s Principal Diplomatic Correspondent Siddhant Sibbal that his country is on the lookout for an efficient, secure, and affordable vaccine. He explained that he wants to show my country, the trust and confidence that the vaccine will work.
Indian vaccines part of solution, says Ecuador envoy during Phase 3 trials of Covaxin
He is the first foreign envoy to be part of Phase 3 COVID-19 vaccine trials in India. Ecuadorian envoy Hector Cueva Jacome and his wife Toya Cardenas Saldarriaga.
Share
Updated: Jan 7, 2021, 05:08 PM IST
Ecuador’s ambassador to India Hector Cueva Jacome, who participated in the phase 3 trials of COVAXIN has expressed his confidence in Indian COVID vaccines, highlighting that are ‘part of the solution’. Speaking exclusively to WION, Ambassador Hector Cueva Jacome said, “I participated in medical trials and it is the best way to show my trust and confidence in the Indian pharmaceutical industry, the Indian vaccine industry.”